Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata is caused by an immune response, and targeting immune cells might help treat it.

IFN-γ and IL-2 are important for T cell activation in hair loss in mice.

Arg1+ macrophages may play a role in Alopecia Areata, offering new treatment targets.

Tislelizumab can cause cutaneous lupus erythematosus.

Farudodstat may help prevent hair loss in alopecia areata by stopping immune attacks on hair follicles.

Alopecia areata involves persistent gene abnormalities and immune activity, even in regrown hair, suggesting a risk of relapse.

The muscle damage was caused by T-cell large granular lymphocytic leukemia, not dermatomyositis.

Sequential immunotherapy can effectively treat alopecia areata by managing inflammation and promoting hair regrowth.

Gamma delta T cells in the skin help with healing and defense but can also cause autoimmune issues, and more research is needed to understand how they are activated.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

People with acne have more CD4+ immune cells in their skin than healthy people.

Alopecia areata involves immune system issues and specific cell types that disrupt hair growth, leading to hair loss.

Activating TLR3 may help produce retinoic acid, important for tissue regeneration.

Plasmacytoid dendritic cells, which overproduce IFN-α, may play a crucial role in starting alopecia areata, an autoimmune disease causing hair loss.

Increased T cell activity may predict hair regrowth success with minoxidil in severe alopecia areata.

CD4+ skin cells may be precursors to basal cell carcinoma.

ARQ-234, a protein designed to treat atopic dermatitis, shows increased effectiveness in early testing.

Immune-epithelial interactions are crucial for tissue repair, but unchecked can cause diseases.

Interferon alfa-2a is effective for treating cutaneous T cell lymphoma but has significant side effects.

Ruxolitinib helped a patient with alopecia areata regrow hair.

Dendritic epidermal T cells help wounds heal faster by boosting skin stem cell growth.

Combining tacrolimus with excimer light is more effective for treating alopecia areata than using excimer light alone.

The document concludes that computational models are useful for understanding immune responses and could improve cancer immunotherapy.

The study's results on the effectiveness of low-dose IL-2 for alopecia areata and its impact on immune cells were not provided.

Lymphocytes, a type of immune cell, are crucial for wound healing as they help remodel damaged areas and reduce inflammation.

Alternative treatments are needed when Tofacitinib alone fails for alopecia areata.

Innate immunity genes in hair follicle stem cells might have new roles beyond traditional immune functions.

The CD4 protein may play a role in the behavior of certain skin cells, affecting their growth, movement, and differentiation.

Atopic dermatitis and alopecia areata share immune and genetic factors, and targeted therapies may help both.

Atopy and altered T cell functions contribute to Alopecia Areata.